Condition 1: Female infertility, unspecified. Condition 2: Male infertility. inability to achieve a pregnancy Azoospermia NOS
Conditions
Interventions
Intervention 1: Intervention: application of progesterone 400 mg vaginal suppository Cyclogest once daily from the day of IUI until negative beta HCG or 12 week. Intervention 2: Controi: no drug.
Treatment - Drugs
Intervention: application of progesterone 400 mg vaginal suppository Cyclogest once daily from the day of IUI until negative beta HCG or 12 week
Controi: no drug
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All women included in the study were between the age 18 and 35 years and BMI of 18-28 kg/m2, regular mense, and no PCOD (according to Rotterdam criteria), basal FSH10 IU/mL, presence of resistant ovarian cyst (>20mm for > 1 months), hypogonadotrophic hypogonadism or any contraindications for progesterone therapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: 4 weeks after insemination. Method of measurement: Transvaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ovulation rate. Timepoint: The days 12, 14 cycles. Method of measurement: Transvaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboobeh Rahmani
Tehran University of Medical Science, Shariati Hospital
Outcome results
None listed